Search Results for agency_names:"Centers for Disease Control and Prevention"

The Centers for Disease Control and Prevention (CDC) is seeking public comments on a proposed information collection related to the National Ambulatory Medical Care Survey (NAMCS) as part of a process for approval by the Office of Management and Budget (OMB). The CDC invites feedback on the necessity and methodology of the survey, ways to enhance the quality and clarity of collected information, and methods to minimize the respondents' burden. The NAMCS provides essential data on ambulatory medical care in the U.S. and aims to sample advanced practice providers, physicians, and health centers over the next few years. Public comments are encouraged within 30 days of this notice's publication.

The Centers for Disease Control and Prevention (CDC) has submitted a request to extend a program that collects feedback on its services, seeking approval from the Office of Management and Budget (OMB). The feedback aims to improve CDC service delivery by gathering customer insights through a non-statistical method. This extension is part of the CDC's ongoing efforts to enhance service quality, as required by Executive Order 12862. The CDC is inviting public comments on the proposal and expects to continue the program for three more years, following approval.

The document announces a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, hosted by the CDC. This meeting, scheduled for June 22-24, 2021, from 8:30 a.m. to 5:00 p.m. EDT via web conference, will review and evaluate grant applications related to violence prevention strategies aimed at reducing youth violence. The meeting is closed to the public to protect confidential trade secrets and personal privacy associated with the grant applications. Dr. Mikel Walters is the contact person for further information regarding the meeting.

The Centers for Disease Control and Prevention (CDC) is seeking public feedback on a draft policy statement regarding biosafety for outdoor large animal studies involving the bacteria Brucella abortus and Brucella suis. This policy aims to guide the development of biosafety plans that comply with regulations set by both the CDC and the U.S. Department of Agriculture (USDA) for research on these bacteria, which pose a threat to human and animal health. The draft policy is available for review, and public comments can be submitted until March 16, 2021, through the provided methods. The policy's goal is to enhance safety protocols for studies on the diseases caused by these bacteria, which affect several animal species and can be transmitted to humans.

The Centers for Disease Control and Prevention (CDC) has submitted a request to the Office of Management and Budget (OMB) for approval of their National Health and Nutrition Examination Survey (NHANES), which includes changes for 2021-2022 due to the COVID-19 pandemic. These changes involve adjustments to survey design, interview modes, and examination procedures, such as conducting more phone interviews and adding COVID-related questions. The CDC invites public comments on the necessity, accuracy, and burden of this information collection effort and seeks to gather public feedback within 30 days of the notice publication. Participation in NHANES remains voluntary, and responses are kept confidential.

The Centers for Disease Control and Prevention (CDC) has issued an order requiring passengers flying to the United States from foreign countries to present proof of a negative COVID-19 test or documentation of recovery from the virus. This order, effective January 26, 2021, supersedes a previous order and aims to prevent the spread of COVID-19, including new variants, by setting requirements for airlines and passengers. Exemptions include certain federal law enforcement and military personnel, as well as cases of emergency travel under specific circumstances. Airlines must verify and retain documentation for compliance, and failure to do so may result in penalties.

The Centers for Disease Control and Prevention (CDC) is inviting public comments on a proposed information collection project focused on HIV prevention for Latina transgender women who have sex with men. The project, named ChiCAS, aims to evaluate a locally developed intervention designed to promote condom use, pre-exposure prophylaxis (PrEP), and medically supervised hormone therapy. The study will involve a quantitative assessment and interviews to measure participants' HIV risk behaviors and the intervention's effectiveness in improving health outcomes. The CDC is following the requirements of the Paperwork Reduction Act of 1995 to seek feedback and approval for this proposed data collection.

The Centers for Disease Control and Prevention (CDC) is seeking public comments on an information collection titled "Improving Fetal Alcohol Spectrum Disorders Prevention and Practice through National Partnerships." They plan to gather data from healthcare workers and organizations involved in the prevention and treatment of fetal alcohol spectrum disorders (FASDs). The goal is to evaluate training programs and their impact on healthcare practices. The public is invited to submit comments on whether the information collection is necessary and how it could be improved.

The Centers for Disease Control and Prevention (CDC) has announced the cancellation of the Advisory Committee on Immunization Practices (ACIP) meeting that was scheduled for February 26-28, 2025. A new date for this meeting will be set, and there will be an opportunity for public comment before the meeting occurs. The notice of this cancellation was originally published in the Federal Register on January 10, 2025. For updates or more information, individuals can contact Stephanie Thomas at the CDC.

The Centers for Disease Control and Prevention (CDC) is seeking public comments on its updated survey for the National Breast and Cervical Cancer Early Detection Program. This program helps increase cancer screenings among underserved women. The revised survey includes changes to questions about partnerships and patient payments, and removes COVID-19-related questions. The CDC encourages feedback on the survey's necessity, accuracy, and how it could reduce the burden on those who participate, with the goal of improving cancer screening access and outcomes.